# Acute Promyelocytic Leukemia 2006 (APL)

> **NCT00378365** · PHASE3 · UNKNOWN · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 800 (estimated)

## Conditions studied

- Leukemia, Promyelocytic, Acute

## Interventions

- **PROCEDURE:** Arsenic trioxide
- **PROCEDURE:** ATRA

## Key facts

- **NCT ID:** NCT00378365
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-10
- **Primary completion:** 2016-09
- **Final completion:** 2016-09
- **Target enrollment:** 800 (ESTIMATED)
- **Last updated:** 2014-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00378365

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00378365, "Acute Promyelocytic Leukemia 2006 (APL)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00378365. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*